Organophosphates |
Liver microsomes, CYP-1A2, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, 3A4, and 3A5 (Hodgson, 2003) |
Organophosphates share P450s for metabolism (Tang et al., 2001; Rose and Hodgson, 2005). Chlorpyrifos-oxonase (PON1) polymorphism is incorporated into chlorpyrifos PBPK model (Timchalk et al., 2002a) |
Metals/metalloids |
Glutathione, cystein (Quig, 1998; Patrick, 2003), arsenic methyltransferase (arsenic) (Drobna et al., 2004; Meza et al., 2005; Wood et al., 2006; Thomas et al., 2007), metallothionein (Nordberg and Nordberg, 2000), divalent metal transporter-1 (DMT1) (Garrick et al., 2003; Bressler et al., 2004), bone mineral exchange (lead) |
Interactions with essential elements (Goyer, 1997; Ballatori, 2002). Arsenic metabolism affected by CYT19, hNP, and hGSTO1-1 genotypes (Drobna et al., 2004; Meza et al., 2005). Cadmium and lead can alter P450 levels and activities (Moore, 2004; Baker et al., 2005). Metal speciation significantly alters toxicity (Yokel et al., 2006) |
VOCs |
Glutathione, glutathione-S-transferase, CYP-2E1, 2C6, 2C11, 1A1, and 1A2 (Reddy et al., 2005) |
GST genotypes effect metabolism and toxicity (Haber et al., 2002; Qu et al., 2003; Dirksen et al., 2004; Silva Mdo et al., 2004; Reddy et al., 2005) |